Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Leonardo C Clavijo, MD, PhD

    TitleAssociate Professor of Clinical Medicine
    SchoolKeck School of Medicine of USC
    DepartmentMedicine
    AddressHCC 300N
    Health Sciences Campus
    Los Angeles California 90089-9198
    Phone+1 323 442 6130
    vCardDownload vCard
      Other Positions
      TitleDirector, Interventional Cardiology Fellowship Program


      Collapse Overview 
      Collapse Overview
      Dr. Clavijo's clinical interests include non-surgical treatment of complex vascular disease, peripheral arterial disease, peripheral vascular disease, carotid disease and interventional cardiology. His research interests include percutaneous coronary interventions, critical limb ischemia, endovascular treatment of peripheral arterial and venous vascular disease and vascular biology.

      Dr. Clavijo earned his medical degree from Universidad Nacional de Colombia. He then went on to complete his Masters of Science in Physiology & Biophysics and Doctor of Philosophy in Physiology & Biophysics from the University of Louisville School of Medicine.


      Collapse Biography 
      Collapse Clinical Trials

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Teixeira PG, Clavijo L, Wilcox AG, Weaver FA. Computerized tomography angiography by direct intra-aortic low volume contrast injection in patients being evaluated for EVAR. Vascular. 2017 Oct; 25(5):451-458. PMID: 28118783.
        View in: PubMed
      2. Flores E, Lewinger JP, Rowe VL, Woo K, Weaver FA, Shavelle D, Clavijo L, Garg PK. Increased risk of mortality after lower extremity bypass in individuals with acute kidney injury in the Vascular Quality Initiative. J Vasc Surg. 2017 Apr; 65(4):1055-1061. PMID: 27865637.
        View in: PubMed
      3. Ward R, Dunn J, Clavijo L, Shavelle D, Rowe V, Woo K. Outcomes of Critical Limb Ischemia in an Urban, Safety Net Hospital Population with High WIfI Amputation Scores. Ann Vasc Surg. 2017 Jan; 38:84-89. PMID: 27546850.
        View in: PubMed
      4. Essilfie G, Shavelle DM, Tun H, Platt K, Kobayashi R, Mehra A, Matthews RV, Clavijo L, Gaglia MA. Association of elevated triglycerides and acute myocardial infarction in young Hispanics. Cardiovasc Revasc Med. 2016 Dec; 17(8):510-514. PMID: 27432210.
        View in: PubMed
      5. Clavijo L, Cortes GA, Jolly A, Tun H, Mehra A, Gaglia MA, Shavelle D, Matthews RV. Same-day discharge after coronary stenting and femoral artery device closure: A randomized study in stable and low-risk acute coronary syndrome patients. Cardiovasc Revasc Med. 2016 Apr-May; 17(3):155-61. PMID: 27157292.
        View in: PubMed
      6. Clavijo L, Maya J, Carlson G, Angiolillo DJ, Teng R, Caplan R, Price MJ. Platelet inhibition with ticagrelor versus clopidogrel in Hispanic patients with stable coronary artery disease with or without diabetes mellitus. Cardiovasc Revasc Med. 2015 Dec; 16(8):450-4. PMID: 26440227.
        View in: PubMed
      7. Elsayed S, Clavijo L. Critical limb ischemia. Cardiol Clin. 2015 Feb; 33(1):37-47. PMID: 25439329.
        View in: PubMed
      8. Clavijo L. Vascular disease. Preface. Cardiol Clin. 2015 Feb; 33(1):ix. PMID: 25439338.
        View in: PubMed
      9. Price MJ, Clavijo L, Angiolillo DJ, Carlson G, Caplan R, Teng R, Maya J. A randomised trial of the pharmacodynamic and pharmacokinetic effects of ticagrelor compared with clopidogrel in Hispanic patients with stable coronary artery disease. J Thromb Thrombolysis. 2015 Jan; 39(1):8-14. PMID: 25305090; PMCID: PMC4300410.
      10. Azarbal A, Clavijo L, Gaglia MA. Antiplatelet therapy for peripheral arterial disease and critical limb ischemia: guidelines abound, but where are the data? J Cardiovasc Pharmacol Ther. 2015 Mar; 20(2):144-56. PMID: 25079473.
        View in: PubMed
      11. Gaglia MA, Shavelle DM, Tun H, Bhatt J, Mehra A, Matthews RV, Clavijo L. African-American patients are less likely to receive drug-eluting stents during percutaneous coronary intervention. Cardiovasc Revasc Med. 2014 Jun; 15(4):214-8. PMID: 24814420.
        View in: PubMed
      12. Gaglia MA, Clavijo L. Cardiovascular pharmacology core reviews: aspirin. J Cardiovasc Pharmacol Ther. 2013 Nov; 18(6):505-13. PMID: 24057863.
        View in: PubMed
      13. Prasad A, Zareh M, Doherty R, Gopal A, Vora H, Somma K, Mehra A, Clavijo L, Matthews RV, Shavelle DM. Use of regadenoson for measurement of fractional flow reserve. Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):369-74. PMID: 23765847.
        View in: PubMed
      14. Gopal A, Aranson N, Woo K, Clavijo L, Shavelle DM. Recalcitrant peroneal artery pseudoaneurysm in a patient with Hemophilia B. Cardiovasc Revasc Med. 2013 Nov-Dec; 14(6):359-62. PMID: 23773548.
        View in: PubMed
      15. Al-Ameri H, Clavijo L, Matthews RV, Kloner RA, Shavelle DM. Devices to treat peripheral chronic total occlusions. J Interv Cardiol. 2012 Aug; 25(4):395-403. PMID: 22564193.
        View in: PubMed
      16. Shah R, Thomson A, Atianzar K, Somma K, Mehra A, Clavijo L, Matthews RV, Shavelle DM. Percutaneous left ventricular support for high-risk PCI and cardiogenic shock: who gets what? Cardiovasc Revasc Med. 2012 Mar-Apr; 13(2):101-5. PMID: 22406055.
        View in: PubMed
      17. Shavelle DM, Clavijo L, Matthews RV. Percutaneous devices to support the left ventricle. Expert Rev Med Devices. 2011 Nov; 8(6):681-94. PMID: 22029466.
        View in: PubMed
      18. Nguyen TH, Clavijo L, Naqvi TZ. Acute ST segment elevation during exercise stress echocardiography due to severe pulmonary hypertension. Cardiovasc Ultrasound. 2011 Jun 06; 9:18. PMID: 21645399; PMCID: PMC3118137.
      19. Zada G, Terterov S, Russin J, Clavijo L, Giannotta S. Cerebral vasospasm and concurrent left ventricular outflow tract obstruction: requirement for modification of hyperdynamic therapy regimen. Neurocrit Care. 2010 Apr; 12(2):265-8. PMID: 19816811.
        View in: PubMed
      20. Chen SF, El-Bialy A, Matthews R, Clavijo L. Use of drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction. J Invasive Cardiol. 2009 Nov; 21(11):E206-12. PMID: 19901420.
        View in: PubMed
      21. Das P, Clavijo L, Nanjundappa A, Dieter RS. Revascularization of carotid stenosis before cardiac surgery. Expert Rev Cardiovasc Ther. 2008 Nov; 6(10):1393-6. PMID: 19018692.
        View in: PubMed
      22. Zbinden S, Clavijo L, Kantor B, Morsli H, Cortes GA, Andrews JA, Jang GJ, Burnett MS, Epstein SE. Interanimal variability in preexisting collaterals is a major factor determining outcome in experimental angiogenesis trials. Am J Physiol Heart Circ Physiol. 2007 Apr; 292(4):H1891-7. PMID: 17189353.
        View in: PubMed
      23. Clavijo L, Steinberg DH, Torguson R, Kuchulakanti PK, Chu WW, Fournadjiev J, Satler LF, Kent KM, Suddath WO, Waksman R, Pichard AD. Sirolimus-eluting stents and calcified coronary lesions: clinical outcomes of patients treated with and without rotational atherectomy. Catheter Cardiovasc Interv. 2006 Dec; 68(6):873-8. PMID: 17086529.
        View in: PubMed
      24. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo L, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2006 Dec 15; 98(12):1563-6. PMID: 17145210.
        View in: PubMed
      25. Javaid A, Chu WW, Cheneau E, Clavijo L, Satler LF, Kent KM, Weissman NJ, Pichard AD, Waksman R. Comparison of paclitaxel-eluting stent and sirolimus-eluting stent expansion at incremental delivery pressures. Cardiovasc Revasc Med. 2006 Oct-Dec; 7(4):208-11. PMID: 17174865.
        View in: PubMed
      26. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo L, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006 Jul; 68(1):62-6. PMID: 16755592.
        View in: PubMed
      27. Chu WW, Kuchulakanti PK, Wang B, Torguson R, Clavijo L, Pichard AD, Suddath WO, Satler LF, Kent KM, Waksman R. Bivalirudin versus unfractionated heparin in patients undergoing percutaneous coronary intervention after acute myocardial infarction. Cardiovasc Revasc Med. 2006 Jul-Sep; 7(3):132-5. PMID: 16945819.
        View in: PubMed
      28. Kuchulakanti PK, Chu WW, Torguson R, Clavijo L, Wolfram R, Mishra S, Xue Z, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R. Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus. Am J Cardiol. 2006 Jul 15; 98(2):187-92. PMID: 16828590.
        View in: PubMed
      29. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo L, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006 Apr; 67(4):595-9. PMID: 16532495.
        View in: PubMed
      30. Chu WW, Kuchulakanti PK, Wang B, Clavijo L, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention. J Interv Cardiol. 2006 Apr; 19(2):121-5. PMID: 16650239.
        View in: PubMed
      31. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo L, Kim SW, Bui A, Gevorkian N, Xue Z, Smith K, Fournadjieva J, Suddath WO, Satler LF, Pichard AD, Kent KM, Waksman R. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006 Feb 28; 113(8):1108-13. PMID: 16490815.
        View in: PubMed
      32. Clavijo L, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Waksman R, Pichard AD. Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients. Am J Cardiol. 2006 Apr 01; 97(7):981-3. PMID: 16563900.
        View in: PubMed
      33. Kuchulakanti PK, Torguson R, Chu WW, Canos DA, Rha SW, Clavijo L, Deible R, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2006 Mar 15; 97(6):792-7. PMID: 16516578.
        View in: PubMed
      34. Chu WW, Kuchulakanti PK, Rha SW, GebreEyesus A, Aggrey G, Torguson R, Wang B, Xue Z, Clavijo L, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary intervention. Am J Cardiol. 2006 Mar 01; 97(5):606-10. PMID: 16490422.
        View in: PubMed
      35. Clavijo L, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med. 2006 Jan-Mar; 7(1):7-11. PMID: 16513517.
        View in: PubMed
      36. Pakala R, Stabile E, Jang GJ, Clavijo L, Waksman R. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis. J Cardiovasc Pharmacol. 2005 Oct; 46(4):481-6. PMID: 16160601.
        View in: PubMed
      37. Burnett MS, Lee CW, Kinnaird TD, Stabile E, Durrani S, Dullum MK, Devaney JM, Fishman C, Stamou S, Canos D, Zbinden S, Clavijo L, Jang GJ, Andrews JA, Zhu J, Epstein SE. The potential role of resistin in atherogenesis. Atherosclerosis. 2005 Oct; 182(2):241-8. PMID: 16159596.
        View in: PubMed
      38. Kuchulakanti P, Wolfram R, Torguson R, Rha SW, Cheneau E, Clavijo L, Chu WW, Pinnow EE, Canos D, Satler LF, Suddath WO, Pichard AD, Kent KM, Waksman R. Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy. Cardiovasc Revasc Med. 2005 Oct-Dec; 6(4):154-9. PMID: 16326376.
        View in: PubMed
      39. Kuchulakanti PK, Torguson R, Canos D, Rha SW, Chu WW, Clavijo L, Deible R, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients. Am J Cardiol. 2005 Oct 15; 96(8):1100-6. PMID: 16214445.
        View in: PubMed
      40. Mofrad PS, Weigold G, Clavijo L. Sudden cardiac death in athlete with anomalous single coronary artery. Cardiovasc Revasc Med. 2005 Apr-Jun; 6(2):89-90. PMID: 16459367.
        View in: PubMed
      41. Clavijo L, Yar O, Kuchulakanti P, Chu WW, Suddath WO, Satler LF, Kent KM, Waksman R, Pichard AD. MRI evaluation of a coronary artery perforation. Cardiovasc Revasc Med. 2005 Jan-Mar; 6(1):44-5. PMID: 16263356.
        View in: PubMed
      42. Clavijo L, Kuchulakanti P, Chu WW, Weigold G, Pichard AD, Waksman R, Boyce SW, Satler LF, Kent KM. "Hybrid" approach for the treatment of a giant left main coronary artery aneurysm. Cardiovasc Radiat Med. 2004 Jul-Sep; 5(3):153-4. PMID: 15721852.
        View in: PubMed
      43. Epstein SE, Stabile E, Kinnaird T, Lee CW, Clavijo L, Burnett MS. Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. Circulation. 2004 Jun 15; 109(23):2826-31. PMID: 15197154.
        View in: PubMed